Research ArticleFragile X Syndrome

Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABAB Receptors with Arbaclofen

See allHide authors and affiliations

Science Translational Medicine  19 Sep 2012:
Vol. 4, Issue 152, pp. 152ra128
DOI: 10.1126/scitranslmed.3004218

Log in to view full text

Log in through your institution

Log in through your institution

Navigate This Article